Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anorexia nervosa, zinc deficiency and the glutamate system: The ketamine option
Daniel F. Hermens, Gabrielle Simcock, Megan Dutton, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 101, pp. 109921-109921
Closed Access | Times Cited: 24

Showing 24 citing articles:

Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review
Zach Walsh, Özden Merve Mollaahmetoğlu, Joseph M. Rootman, et al.
BJPsych Open (2021) Vol. 8, Iss. 1
Open Access | Times Cited: 126
Therapeutic Potentials of Ketamine and Esketamine in Obsessive–Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature
Giovanni Martinotti, Stefania Chiappini, Mauro Pettorruso, et al.
Brain Sciences (2021) Vol. 11, Iss. 7, pp. 856-856
Open Access | Times Cited: 86
Investigation of the influence of Zinc-containing compounds on the components of the colloidal phase of milk
А.В. Блинов, Shahida Anusha Siddiqui, Andrey Nagdalian, et al.
Arabian Journal of Chemistry (2021) Vol. 14, Iss. 7, pp. 103229-103229
Open Access | Times Cited: 51
Zinc levels in severe eating disorders
Kara Leach, Dan V. Blalock, Judy Oakes, et al.
Journal of Eating Disorders (2025) Vol. 13, Iss. 1
Open Access
Ketamine as adjuvant treatment in eating disorders: an exploratory study of a case series and retrospective analysis
Paula Jhoana Escobedo-Aedo, Chris Serrand, Sarah Kabani, et al.
Journal of Eating Disorders (2025) Vol. 13, Iss. 1
Open Access
Rethinking Depression—Beyond Neurotransmitters: An Integrated Psychoneuroendocrineimmunology Framework for Depression’s Pathophysiology and Tailored Treatment
Anna Giulia Bottaccioli, Mauro Bologna, Francesco Bottaccioli
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2759-2759
Open Access
Post-traumatic stress disorder may set the neurobiological stage for eating disorders: A focus on glutamatergic dysfunction
Sidney L. Murray, Kathleen F. Holton
Appetite (2021) Vol. 167, pp. 105599-105599
Closed Access | Times Cited: 24
Hippocampal volume, function, and related molecular activity in anorexia nervosa: A scoping review
Johanna Louise Keeler, Olivia Patsalos, Sandrine Thuret, et al.
Expert Review of Clinical Pharmacology (2020) Vol. 13, Iss. 12, pp. 1367-1387
Closed Access | Times Cited: 27
Ketamine and Zinc: Treatment of Anorexia Nervosa Via Dual NMDA Receptor Modulation
Jules Mitchell, Daniel F. Hermens, Maxwell R. Bennett, et al.
CNS Drugs (2023) Vol. 37, Iss. 2, pp. 159-180
Open Access | Times Cited: 7
Molecular mechanisms underlying the N-methyl-d-aspartate receptor antagonists: Highlighting their potential for transdiagnostic therapeutics
Christina Driver, Timothy N. W. Jackson, Jim Lagopoulos, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 119, pp. 110609-110609
Closed Access | Times Cited: 12
Drugs with glutamate-based mechanisms of action in psychiatry
Adrian Andrzej Chrobak, Marcin Siwek
Pharmacological Reports (2024)
Open Access | Times Cited: 2
Novel ketamine and zinc treatment for anorexia nervosa and the potential beneficial interactions with the gut microbiome
Rosiel Elwyn, Jules Mitchell, Michael Kohn, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 148, pp. 105122-105122
Closed Access | Times Cited: 5
Anorexia Nervosa—What Has Changed in the State of Knowledge about Nutritional Rehabilitation for Patients over the Past 10 Years? A Review of Literature
Katarzyna Jowik, Marta Tyszkiewicz‐Nwafor, Agnieszka Słopień
Nutrients (2021) Vol. 13, Iss. 11, pp. 3819-3819
Open Access | Times Cited: 11
A molecular framework for autistic experiences: Mitochondrial allostatic load as a mediator between autism and psychopathology
Caitlyn Mahony, Colleen O’Ryan
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 7
Individual differences in the positive outcome from adolescent ketamine treatment in a female mouse model of anorexia nervosa involve drebrin A at excitatory synapses of the medial prefrontal cortex
Rose Temizer, Yi‐Wen Chen, Chiye Aoki
Synapse (2022) Vol. 77, Iss. 1
Open Access | Times Cited: 6
Brain Volume Loss, Astrocyte Reduction, and Inflammation in Anorexia Nervosa
Jochen Seitz, Stefanie Trinh, Vanessa Kogel, et al.
Advances in neurobiology (2021), pp. 283-313
Closed Access | Times Cited: 8
Excitatory and inhibitory neurometabolites in anorexia nervosa: A systematic review of proton magnetic resonance spectroscopy studies
Jules Mitchell, Toomas Erik Anijärv, Jacob. L. Levenstein, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 152, pp. 105279-105279
Closed Access | Times Cited: 2
Suppression of food restriction‐evoked hyperactivity in activity‐based anorexia animal model through glutamate transporters GLT‐1 at excitatory synapses in the hippocampus
Olesia M. Bilash, Hannah Actor-Engel, Ang D. Sherpa, et al.
Synapse (2021) Vol. 75, Iss. 7
Closed Access | Times Cited: 5
Apnea with ketamine sedation in a patient with severe anorexia nervosa: A case report
R R Joshi, Whitney Marvin
Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity (2021) Vol. 27, Iss. 1, pp. 387-389
Closed Access | Times Cited: 4
Serum zinc levels in youth with avoidant/restrictive food intake disorder and anorexia nervosa: Clinical correlation with weight and psychopathology
Fauzia Mahr, Marley G. Billman Miller, Marlana A. Quaill, et al.
Nutrition and Health (2023)
Open Access | Times Cited: 1
A Molecular Framework for Autistic Experiences: Mitochondrial Allostatic Load as A Mediator between Autism and Psychopathology
Caitlyn Mahony, Colleen O' Ryan
(2022)
Open Access | Times Cited: 2
A Molecular Framework for Autistic Experiences: Mitochondrial Allostatic Load as A Mediator between Autism and Psychopathology
Caitlyn Mahony, Colleen O' Ryan
(2022)
Open Access | Times Cited: 1
Drug Repurposing Patent Applications July–September 2021
Hermann AM Mucke
Assay and Drug Development Technologies (2021) Vol. 20, Iss. 1, pp. 35-41
Closed Access | Times Cited: 1
Pharmakotherapie bei Essstörungen
Daniel Watolla, Stephan Zipfel, Andreas Stengel
PSYCH up2date (2023) Vol. 17, Iss. 03, pp. 221-239
Closed Access
Page 1

Scroll to top